Britain's AstraZeneca said its vaccine against the novel coronavirus could be around 90% effective without any serious side effects. The combined analysis from both dosing regimens resulted in an average efficacy of 70%. The vaccine is better suited for India as it can be kept at refrigerator temperature, unlike the drugs developed by Pfizer and Moderna.
